Long-form, occasionally.

• 24 July 2026 · April data
  A quadrupled bill, a shrinking antibiotic and a stalled blockbuster
  April's NHSBSA release holds three stories worth a commercial team's time: an anticoagulant whose monthly bill quadrupled while volumes stood still, an antibiotic still shedding 15% a year, and the GLP-1 that stopped growing. All of it from open data.
  7 min read
• 12 June 2026 · Methodology
  Why 'items' isn't 'patients', and why nobody tells you
  Every prescribing chart you have ever read is a chart of items dispensed. Item counts are not patient counts. Here is the difference in numbers, and what it does to a market-share slide.
  7 min read
• 3 May 2026 · ICB variation
  The four ICBs still writing brand where the guidelines say generic
  Three years after the switch, four Integrated Care Boards still prescribe branded apixaban above the national average. We look at why the pattern hasn't broken.
  9 min read
• 1 April 2026 · Hospital data
  SCMD, translated: what you actually get for your five-line CSV request
  Secondary Care Medicines Data is powerful and quietly awful to use. A short primer on the joins that matter, the joins that don't, and the joins the NHS won't do for you.
  11 min read

No archive older than shown — DoseTrend Insights launched in April 2026.